Nordic Society of Gynecologic Oncology

What Nordic Society of Gynecologic Oncology does

The Nordic Society of Gynecological Oncology (NSGO) is a Denmark-domiciled non-profit professional society founded in November 1986 in Oslo by representatives from Denmark, Finland, Norway, and Sweden. It operates as a dual-entity organization: NSGO-The Society, a membership body of over 300 gynecological oncologists, pathologists, researchers, nurses, and patient advocates across the Nordic and Baltic regions (Denmark, Finland, Iceland, Norway, Sweden, plus associate members Lithuania and Estonia), and NSGO-CTU (Clinical Trial Unit), a separate non-profit foundation established in 2006 at Rigshospitalet, Copenhagen University Hospital, that manages and conducts clinical trials in gynecological oncology. The organization is governed by an elected Executive Board with country representation and overseen by a President (currently Trine Jakobi Nøttrup, 2024-2027), with a Medical Director leading the Clinical Trial Unit.

NSGO's core products and services include: a professional membership program with Full and Associate tiers; a clinical trial portfolio covering cervical, endometrial, ovarian, surgical, and real-world evidence studies; the NSGO Annual Meeting (2026 edition in Tromsø, Norway); biannual investigator meetings; the NSGO Gynaecological Cancer Research Grant (up to €20,000 per project); and educational resources including a FAQ & Glossary. Technology consists of clinical trial management and data management systems (REDCap referenced via a dedicated project manager role) used to coordinate trials across the Nordic cancer center network. NSGO-CTU holds international affiliations with ENGOT (European Network for Gynaecological Oncological Trials) and GOG, enabling participation in global gynecological oncology trials.

The business model is multi-stream non-profit revenue: annual membership subscriptions, tiered event registration fees (€300-€1,000 per attendee), pharmaceutical company sponsorships for the Annual Meeting (8 confirmed sponsors for 2026 including AbbVie, AstraZeneca, Daiichi Sankyo, Eisai, GSK, MSD as Gold Sponsors and Lilly, Mural Oncology as Exhibitors), and outbound research grants funded from society resources. GTM is community-led, with member acquisition through professional networks, conferences, and trial collaborations. The NSGO-CTU office employs approximately 10-15 staff including project managers, a clinical trial manager, contract manager, financial coordinator, and data management specialists.

Name

Nordic Society of Gynecologic Oncology

Legal name

Nordic Society of Gynaecological Oncology

Website

https://nsgo.org

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

NSGO is a Denmark-based non-profit professional society of 300+ gynecological oncology clinicians and researchers across the Nordic and Baltic regions, operating NSGO-CTU as its affiliated clinical trial unit to run international gynecological cancer trials.

Ownership category

akta.pro rank

Product category

Medical Professional Society & Clinical Research Services

NAICS

Offices of Physicians (62111), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Membership Organizations (8600), Services-Health Services (8000)

akta.pro primary industry

Gynecologic Oncology (HLAKAFAF)

akta.pro secondary industry

Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Gynecologic oncology research
• Clinical trial coordination
• Medical professional society
• Oncology medical education
• Multi-center clinical studies

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: Annual membership fees from healthcare professionals in the Nordic and Baltic regions
2. Event Registration Fees: Registration fees for Annual Meetings and Investigator Meetings, with tiered pricing for members and non-members
3. Research Grants: NSGO provides gynecological cancer research grants to early-career researchers, funded through society resources
4. Sponsorships: Pharmaceutical company sponsors (Gold sponsors: AbbVie, AstraZeneca, Daiichi Sankyo, Eisai, GSK, MSD; Exhibitors: Lilly, Mural Oncology) for annual meetings and events

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The Nordic Society of Gynecologic Oncology (NSGO) is a non-profit professional medical society serving gynecological oncologists, pathologists, researchers, nurses, and patient advocates across the Nordic and Baltic countries. Through its companion clinical trial unit (NSGO-CTU), the organization designs, coordinates, and conducts multi-center clinical trials in gynecologic oncology, and delivers membership services, scientific meetings, and continuing medical education to its members.

Product overview

NSGO operates as a dual-structure organization consisting of NSGO-The Society (a professional membership society with over 300 members) and NSGO-CTU (Clinical Trial Unit). The Society provides membership, annual meetings, networking, and research grants for professionals dedicated to gynecological cancer care. The Clinical Trial Unit manages and supports clinical research through organized trial portfolios covering cervical, endometrial, ovarian, and surgical trials, plus real world evidence studies. Both entities collaborate to advance gynecological oncology in Nordic and Baltic regions through education, clinical research, and international partnerships with ENGOT and GOG.

Differentiator

Problem solved

Functional benefit

Products and services

• NSGO Society Membership
• NSGO Clinical Trial Unit (NSGO-CTU) Services
• NSGO Scientific Meetings and Congresses
• NSGO Working Groups

Quantifiable outcome

• Founded 1986, has grown to over 300 members across Nordic and Baltic regions
• +1 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Eleven partnerships are on record, tiered core and minor.

• ENGOT (European Network for Gynaecological Oncological Trials)coreStrategic or Co-development PartnerNSGO-CTU is affiliated with ENGOT and participates in international clinical trials coordinated through this network. ENGOT enables NSGO to join global gynecological oncology trials and contribute to international research collaboration.
• GOG (Gynecologic Oncology Group)coreStrategic or Co-development PartnerNSGO maintains partnerships with GOG to advance clinical research in gynecological oncology. This collaboration enables participation in international clinical trials and research initiatives.
• AbbVieminorOthersGold Sponsor of NSGO Annual Meeting 2026
• AstraZenecaminorOthersGold Sponsor of NSGO Annual Meeting 2026
• Daiichi SankyominorOthersGold Sponsor of NSGO Annual Meeting 2026
• EisaiminorOthersGold Sponsor of NSGO Annual Meeting 2026
• GSKminorOthersGold Sponsor of NSGO Annual Meeting 2026
• MSDminorOthersGold Sponsor of NSGO Annual Meeting 2026
• LillyminorOthersExhibitor at NSGO Annual Meeting 2026
• Mural OncologyminorOthersExhibitor at NSGO Annual Meeting 2026
• Nordic Cancer CenterscoreStrategic or Co-development PartnerNSGO collaborates with specialized cancer centers across Nordic countries (Denmark, Finland, Iceland, Norway, Sweden) for clinical trial conduct and research collaboration. Baltic regions (Lithuania, Estonia) are associate members.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• AGO (Arbeitsgemeinschaft Gynäkologische Onkologie): German gynecologic oncology working group with similar structure to NSGO: physician-led society coordinating clinical trials and guidelines. Comparable on national-level trial coordination and pharma-sponsored study portfolio.
• BGOG (Belgian and Luxembourg Gynaecological Oncology Group): Belgian/Luxembourg gynecologic oncology clinical trials group; similar scale and structure to NSGO-CTU. Comparable on running pharma-sponsored interventional trials and investigator meetings.
• ENGOT (European Network of Gynaecological Oncological Trial groups): Umbrella network coordinating European gynecologic oncology trial groups; NSGO-CTU is an active member and ENGOT rep sits within NSGO-CTU. Direct comparison on trial coordination infrastructure, multi-country trial conduct, and pharma engagement.
• GOG (Gynecologic Oncology Group, now part of NRG Oncology): US-based gynecologic oncology clinical trials group; NSGO partners with GOG on international trials. Directly comparable on clinical trial design, sponsor management, and gynecologic cancer portfolio focus.
• GCIG (Gynecological Cancer Intergroup): Global intergroup of national gynecologic oncology trial groups; NSGO-CTU holds a GCIG representative role. Directly comparable as a coordinating body for international gynecologic oncology trials.

Others

• Nordic Cancer Union (NCU): Inter-governmental Nordic cooperation on cancer policy, research funding, and information. Tangentially comparable as a Nordic-level cancer coordination body, but does not run clinical trials directly.

Broad incumbents

• ESGO (European Society of Gynaecological Oncology): European professional society covering the broader gynecologic oncology field including education, congresses, and guidelines. Comparable as a European professional society but broader in scope than NSGO's regional Nordic-Baltic focus.
• SGO (Society of Gynecologic Oncology): US national professional society for gynecologic oncologists. Comparable on membership model, annual meetings, and educational programs, though NSGO is more regionally focused and includes an active clinical trial unit.
• IGCS (International Gynecologic Cancer Society): International society for gynecologic cancer professionals. Comparable on global membership, education, and congress activities; NSGO has a more regionally concentrated trial operations footprint.

Regional players

• NCRI (National Cancer Research Institute): UK-based partnership of cancer research funders and organizers, including clinical trials groups. Comparable on coordinating national cancer research infrastructure and standards, though broader in cancer type scope than NSGO.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/wwwnsgoorg
• LinkedInlinkedin.com/company/nsgo-ctu

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nordic Society of Gynecologic Oncology